Temper cancer care innovations with cost considerations

There may be new breakthroughs announced in cancer care every few months, but the healthcare sector needs to keep in mind something else: Whether the treatments are cost-effective. Paul Keckley, managing director at the Navigant Center for Healthcare Research and Policy Analysis, noted that cancer care costs will reach $173 billion annually by the end of the decade, while oncology costs have risen 20 times faster than the Consumer Price Index over the past 15 years. As a result, Keckley noted that cancer care outcomes are "not guaranteed by our rich legacy--until and unless the relative value question about cancer care management is addressed forthrightly in a meaningful public discussion, its future is uncertain, reserved for fewer and fewer who can afford it." >> Read the full article at FierceHealthcare


Suggested Articles

A commonly used format for formulary submissions has been updated to enable drug companies to share information with payers on unapproved products.

NextGen Healthcare's Rusty Frantz sounded off about hospitals opposing proposed federal data-sharing rules while also sharing data with tech giants.

Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry.